Recent advances in multi-metallic-based nanozymes for enhanced catalytic cancer therapy

Abstract

Nanozymes have emerged as a promising alternative to natural enzymes, effectively addressing natural enzymes’ inherent limitation. Versatility and potential applications of nanozyme span across various fields, with catalytic tumor therapy being one prominent area. This has sparked significant interest and exploration in the utilization of nanozymes for targeted cancer treatment. Recent advancements in interdisciplinary research, nanotechnology, biotechnology, and catalytic technology have led to the emergence of multi-metallicbased nanozymes, which exhibit tremendous potential for further development. This review focuses on investigating the synergistic effects of multimetallic-based nanozymes, aiming to enhance our understanding of their catalytic activities and facilitate their broader applications. We comprehensively survey the remarkable achievements in the synthesis, catalytic mechanisms, and the latest applications of multi-metallic-based nanozymes in cancer catalytic therapy. Furthermore, we identify the current limitations and prospects of multi-metallic-based nanozymes in the development of new materials and the application of novel technologies, along with the potential challenges associated with catalytic cancer therapy. This review underscores the significance of multi-metallic-based nanozymes and emphasizes the need for continued exploration as well as their potential impact on the development of novel materials and the realization of breakthroughs in catalytic tumor therapy.

Keywords

cancer therapy / multi-metallic nanomaterials / nanozyme activities / synergistic effects

RIGHTS & PERMISSIONS

2023 2023 The Authors. BMEMat published by John Wiley & Sons Australia, Ltd on behalf of Shandong University.